Tango Therapeutics Inc (NASDAQ:TNGX) has a beta value of 0.81 and has seen 1.9 million shares traded in the recent trading session. The company, currently valued at $371.16M, closed the recent trade at $3.46 per share which meant it gained $0.41 on the day or 13.29% during that session. The TNGX stock price is -276.01% off its 52-week high price of $13.01 and 21.97% above the 52-week low of $2.70. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.82 million shares traded. The 3-month trading volume is 1.92 million shares.
The consensus among analysts is that Tango Therapeutics Inc (TNGX) is Buy stock at the moment, with a recommendation rating of 1.11. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
Tango Therapeutics Inc (NASDAQ:TNGX) trade information
Sporting 13.29% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TNGX stock price touched $3.46 or saw a rise of 1.14%. Year-to-date, Tango Therapeutics Inc shares have moved 11.82%, while the 5-day performance has seen it change 11.46%. Over the past 30 days, the shares of Tango Therapeutics Inc (NASDAQ:TNGX) have changed -0.42%. Short interest in the company has seen 8.06 million shares shorted with days to cover at 4.51.
Wall Street analysts have a consensus price target for the stock at $15.5, which means that the shares’ value could jump 77.68% from the levels at last check today.. The projected low price target is $13.0 while the price target rests at a high of $18.0. In that case, then, we find that the latest price level in today’s session is -420.23% off the targeted high while a plunge would see the stock gain -275.72% from the levels at last check today..
Tango Therapeutics Inc (TNGX) estimates and forecasts
Figures show that Tango Therapeutics Inc shares have underperformed across the wider relevant industry. The company’s shares have lost -64.04% over the past 6 months, with this year growth rate of -10.19%, compared to 16.90% for the industry.
TNGX Dividends
Tango Therapeutics Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tango Therapeutics Inc (NASDAQ:TNGX)’s Major holders
Insiders own 6.54% of the company shares, while shares held by institutions stand at 107.04% with a share float percentage of 114.53%. Investors are also buoyed by the number of investors in a company, with Tango Therapeutics Inc having a total of 189.0 institutions that hold shares in the company. The top two institutional holders are TRV GP IV, LLC with over 19.2 million shares worth more than $164.75 million. As of 2024-06-30, TRV GP IV, LLC held 17.751% of shares outstanding.
The other major institutional holder is ECOR1 CAPITAL, LLC, with the holding of over 13.33 million shares as of 2024-06-30. The firm’s total holdings are worth over $114.38 million and represent 12.3237% of shares outstanding.
